Are you curious about the patentability of software? Or interested in learning how to protect and distribute software? Technology Transfer & Business Development will be holding a brown bag session on Software Licensing & Patents on August 7, 2013 in Mac Hall, room 2201, from 12 to 1 p.m. Lunch will be catered (first come, first serve or bring your own). The event will be lead by Arvin Paranjpe, M.S., J.D., technology development manager, and … Read More
Posts Tagged ‘TTBD’
Stay up to date and find out about all of the latest happenings in Tech Transfer & Business Development at OHSU by subscribing to the new TTBD newsletter. Highlights include information on patents, industry partnerships, and more for faculty, research-ranked staff, postdocs and students. To be added to the distribution list contact TTBD.
Find out about all of the latest happenings in Tech Transfer and Business Development at OHSU in the new quarterly TTBD newsletter. Highlights include: The Guide to Technology Transfer and Business Development – A handy online document outlining how our office can assist you Important patent law changes – What is the America Invents Act and how does that relate to patents at OHSU? Success story – Neuro Kinetics Inc. has licensed software from OHSU … Read More
Have you ever wondered if a discovery of yours has commercial value or had questions about who to contact about an invention? Maybe you have questions about filling out an Intellectual Property Disclosure form? Technology Transfer & Business Development will be holding a brown bag session on “Intellectual Property & the Invention Disclosure Process” on June 24, 2013 in Mac Hall, room 2201, from 12 to 1 p.m. The Event will be lead by Jeff Jackson, MS, JD, … Read More
The Oregon Clinical & Translational Research Institute is pleased to announce the funding of five research awards through its Biomedical Innovation Program. The Program funds promising translational projects with the goal of moving innovative technologies to clinical application through commercialization. The Biomedical Innovation Program is supported by major funding from OCTRI, with supplemental support from the Oregon Translational Research and Development Institute (OTRADI), and by a strong collaboration with OHSU Technology Transfer and Business Development. … Read More
OHSU has been selected by Novo Nordisk to participate in the Novo Nordisk Diabetes and Obesity Biologics Science Forum Awards. Twenty institutions from the western region have been invited to participate. The objective of this program is to help US scientists substantiate and translate early innovation research efforts and clarify if their hypotheses could result in new treatment options for diabetes and obesity. The awards are for non-clinical research related to new biologic therapeutics and … Read More